Viewing Study NCT00694161

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:10 PM
Ignite Modification Date: 2026-01-20 @ 4:26 AM
Study NCT ID: NCT00694161
Status: COMPLETED
Last Update Posted: 2013-01-11
First Post: 2008-06-06
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: The Effects Of Fx-1006A On Transthyretin Stabilization And Clinical Outcome Measures In Patients With V122I Or Wild-Type TTR Amyloid Cardiomyopathy
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cardiomyopathy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Transthyretin View
None TTR View
None ATTR View
None TTR amyloidosis View
None cardiomyopathy View
None V122I View
None wild-type TTR View
None SSA View
None Patients with V122I or wild-type TTR amyloid cardiomyopathy View